Prospects for immunomodulatory therapy of bronchial asthma

Cover Page

Cite item

Full Text

Abstract

The relevance of pharmacological correction of immunological reactivity is obvious: many socially significant diseases are accompanied by an imbalance in immune homeostasis. In the past few years, a number of reviews on the classification and mechanisms of action of immunotropic drugs approved for clinical use in the Russian Federation have been published in the domestic press.

About the authors

G. V. Cherepnev

Republican Medical Diagnostic Center; Kazan State Medical Academy of Postgraduate Education

Author for correspondence.
Email: info@eco-vector.com

Doctor of Medical Sciences, Head of the Scientific Department, Department of Clinical Pharmacology and Pharmacotherapy

 
Russian Federation, Kazan; Kazan

Y. D. Slabnov

Republican Medical Diagnostic Center; Kazan State Medical Academy of Postgraduate Education

Email: info@eco-vector.com

Scientific Department, Department of Clinical Pharmacology and Pharmacotherapy

Russian Federation, Kazan; Kazan

I. E. Zimakova

Republican Medical Diagnostic Center; Kazan State Medical Academy of Postgraduate Education

Email: info@eco-vector.com

Professor, Head of the Department of Clinical Pharmacology and Pharmacotherapy, Scientific Department

 
Russian Federation, Kazan; Kazan

References


© 1998 Cherepnev G.V., Slabnov Y.D., Zimakova I.E.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies